Transaction in Own Shares
Rhea-AI Summary
Shell (SHEL) announces that on 20 January 2026 it purchased shares for cancellation under its existing buy-back programme announced 30 October 2025. Aggregated trades: 659,433 shares on the LSE at a volume‑weighted average price of £27.2191, and 664,831 shares on XAMS at a volume‑weighted average price of €31.3854. Purchases were made by Merrill Lynch International acting independently under pre‑set parameters and will be cancelled. The programme is conducted under UK MAR and related Listing Rules.
Positive
- Purchased 659,433 shares on LSE at VWAP £27.2191 on 20 January 2026
- Purchased 664,831 shares on XAMS at VWAP €31.3854 on 20 January 2026
- Shares purchased are to be cancelled, reducing outstanding share count under the buy‑back programme
Negative
- None.
Key Figures
Market Reality Check
Peers on Argus
Peers showed mixed, modest moves: CVX -0.2%, XOM +0.75%, TTE +0.55%, BP -0.08%, PBR +0.48%, suggesting this buyback update is more stock-specific than part of a broad sector rotation.
Historical Context
| Date | Event | Sentiment | Move | Catalyst |
|---|---|---|---|---|
| Jan 16 | Share buyback update | Positive | +1.1% | Disclosure of share purchases and cancellations under ongoing buy-back programme. |
| Jan 13 | Share buyback update | Positive | +2.1% | Report of 1.68M shares bought and cancelled across LSE and XAMS. |
| Jan 12 | Share buyback update | Positive | +1.2% | Report of 1.96M shares repurchased and cancelled on LSE and XAMS. |
| Jan 09 | Share buyback update | Positive | +0.7% | Multi-venue buy-backs totalling about 2.09M shares with VWAP ranges disclosed. |
| Jan 08 | Share buyback update | Positive | -1.7% | 2.43M shares repurchased across venues under preset buy-back parameters. |
Recent buyback disclosures have generally coincided with modestly positive next-day price moves, with one notable negative reaction.
Over January 2026, Shell has issued frequent "Transaction in Own Shares" updates detailing daily repurchases and cancellations under its buy-back programme announced on 30 October 2025. Disclosures on Jan 8–16 reported multi-venue purchases ranging from about 655k to over 2.4M shares per day, executed independently by Merrill Lynch International within preset parameters and in compliance with UK/EU MAR. Price reactions over the following 24 hours were mostly positive (four gains, one loss), indicating that ongoing buybacks have often coincided with supportive price action.
Market Pulse Summary
This announcement details additional share repurchases for cancellation on 20 January 2026 across LSE and XAMS under Shell’s ongoing buy-back programme launched on 30 October 2025. It reiterates that Merrill Lynch International executes trades independently within preset parameters and under UK/EU MAR rules. Recent history shows frequent disclosures of multi-venue buybacks and cancellations. Investors may watch the pace of daily repurchases, total shares cancelled over time, and any changes to programme timelines or execution counterparties.
Key Terms
EU MAR regulatory
UK MAR regulatory
off-market buyback contract financial
AI-generated analysis. Not financial advice.
Transaction in Own Shares
20 January, 2026
• • • • • • • • • • • • • • • •
Shell plc (the ‘Company’) announces that on 20 January, 2026 it purchased the following number of Shares for cancellation.
Aggregated information on Shares purchased according to trading venue:
| Date of purchase | Number of Shares purchased | Highest price paid | Lowest price paid | Volume weighted average price paid per share | Venue | Currency |
| 20/01/2026 | 659,433 | 27.3350 | 27.0200 | 27.2191 | LSE | GBP |
| 20/01/2026 | - | - | - | - | Chi-X (CXE) | GBP |
| 20/01/2026 | - | - | - | - | BATS (BXE) | GBP |
| 20/01/2026 | 664,831 | 31.5550 | 31.1750 | 31.3854 | XAMS | EUR |
| 20/01/2026 | - | - | - | - | CBOE DXE | EUR |
| 20/01/2026 | - | - | - | - | TQEX | EUR |
These share purchases form part of the on- and off-market limbs of the Company's existing share buy-back programme previously announced on 30 October 2025.
In respect of this programme, Merrill Lynch International will make trading decisions in relation to the securities independently of the Company for a period from 30 October 2025 up to and including 30 January 2026.
The on-market limb will be effected within certain pre-set parameters and in accordance with the Company’s general authority to repurchase shares on-market. The off-market limb will be effected in accordance with the Company’s general authority to repurchase shares off-market pursuant to the off-market buyback contract approved by its shareholders and the pre-set parameters set out therein. The programme will be conducted in accordance with Chapter 9 of the UK Listing Rules and Article 5 of the Market Abuse Regulation 596/2014/EU dealing with buy-back programmes (“EU MAR”) and EU MAR as “onshored” into UK law from the end of the Brexit transition period (at 11:00 pm on 31 December 2020) through the European Union (Withdrawal) Act 2018 (as amended by the European Union (Withdrawal Agreement) Act 2020), and as amended, supplemented, restated, novated, substituted or replaced by the Financial Services Act, 2021 and relevant statutory instruments (including, The Market Abuse (Amendment) (EU Exit) Regulations (SI 2019/310)), from time to time (“UK MAR”) and the Commission Delegated Regulation (EU) 2016/1052 (the “EU MAR Delegated Regulation”) and the EU MAR Delegated Regulation as “onshored” into UK law from the end of the Brexit transition period (at 11:00 pm on 31 December 2020) through the European Union (Withdrawal) Act 2018 (as amended by the European Union (Withdrawal Agreement) Act 2020), and as amended, supplemented, restated, novated, substituted or replaced by the Financial Services Act, 2021 and relevant statutory instruments (including, The Market Abuse (Amendment) (EU Exit) Regulations (SI 2019/310)), from time to time.
In accordance with EU MAR and UK MAR, a breakdown of the individual trades made by Merrill Lynch International on behalf of the Company as a part of the buy-back programme is detailed below.
Enquiries
Media: International +44 (0) 207 934 5550; U.S. and Canada: https://www.shell.us/about-us/news-and-insights/media/submit-an-inquiry.html
Attachment